Form4.ai tracks every SEC insider trade in real time. See every DRMA insider filing with a free account — no card.
See every DRMA insider filing — free account, no card.
Free accountDermata Therapeutics, Inc. (DRMA) has 2 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 18, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 18, 2026 SEC filing | PROEHL GERALD T PRESIDENT, CHAIRMAN, CEO | Grant / award | — | — |
| Aug 18, 2026 SEC filing | Van Hoose Kyri K. SVP, CFO | Grant / award | — | — |
Create a free account to see all 2 DRMA filings from the last 90 days. No card needed.
Create free accountWant DRMA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.